BALAD score predicts the recurrence and survival in the patients who underwent initial hepatectomy for HCC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

BALAD score predicts the recurrence and survival in the patients who underwent initial hepatectomy for HCC

Published:2024-08 Issue: Volume:55 Page:102097
ISSN:0960-7404
Container-title:Surgical Oncology
language:en
Short-container-title:Surgical Oncology

Author:

Nakagawa Shigeki^ORCID,Hayashi Hiromitsu,Itoyama Rumi,Kitano Yuki,Mima Kosuke,Okabe Hirohisa,Baba Hideo

Publisher

Elsevier BV

Reference33 articles.

1. Rising incidence and demographics of hepatocellular carcinoma in the USA: what does it mean?;Shaw;Expet Rev. Gastroenterol. Hepatol.,2011

2. Primary liver cancer: worldwide incidence and trends;Bosch;Gastroenterology,2004

3. Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum;Burroughs;Lancet Oncol.,2004

4. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan;Arii;Hepatology,2000

5. Optimal initial treatment for early hepatocellular carcinoma in patients with preserved liver function: transplantation or resection?;Poon;Ann. Surg Oncol.,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP